KisoJi Biotechnology is a Canadian antibody therapeutics company focused on discovering and developing differentiated antibody medicines for oncology and other serious diseases. The company has built an in-house platform designed to visualize and interrogate broader antibody diversity than conventional discovery methods. Its work spans next-generation antibody discovery, lead selection, and multispecific or advanced antibody development.